Intellia awards inducement grants under Nasdaq Rule 5635(c)(4)
Intellia Therapeutics said it awarded inducement grants on September 1, 2026 under Nasdaq Listing Rule 5635(c)(4).
CAMBRIDGE, Mass., Sept.
04, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc.
NASDAQ:NTLA, a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that on September 1, 2026, it awarded inducement grants t…